Routine incorporation of the local read in Crohn's disease clinical trials? Not so fast

Affiliations

¹ Department of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada; Alimentiv Inc., London, Ontario, Canada.
² Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada; Alimentiv Inc., London, Ontario, Canada.
³ Alimentiv Inc., London, Ontario, Canada; Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
⁴ Alimentiv Inc., London, Ontario, Canada; Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.

Editorial

Vipul Jairath et al. Gastrointest Endosc. 2021 Jan.

. 2021 Jan;93(1):183-186.

doi: 10.1016/j.gie.2020.08.020.

¹ Department of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada; Alimentiv Inc., London, Ontario, Canada.
² Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada; Alimentiv Inc., London, Ontario, Canada.
³ Alimentiv Inc., London, Ontario, Canada; Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
⁴ Alimentiv Inc., London, Ontario, Canada; Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.

No abstract available

Comment on

Impact of various central endoscopy reading models on treatment outcome in Crohn's disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT trial.
Reinisch W, Mishkin DS, Oh YS, Schreiber S, Hussain F, Jacob R, Hassanali A, Daperno M. Reinisch W, et al. Gastrointest Endosc. 2021 Jan;93(1):174-182.e2. doi: 10.1016/j.gie.2020.05.020. Epub 2020 May 25. Gastrointest Endosc. 2021. PMID: 32464142